Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
SNTI · NASDAQ · Biological Products, (No Diagnostic Substances)
$1.77−1.02 (−36.56%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Senti Biosciences Holdings (SNTI) · oqro.io/stocks/SNTI · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake, activist · Stake as of Nov 16, 2026 · Filed Nov 18, 2026
Bayer HealthCare LLC disclosed a 6.9% stake in SNTI and may seek to influence the companySource5%+ stake, activist · Stake as of Nov 16, 2026 · Filed Nov 18, 2026
New Enterprise Associates 15, L.P. disclosed a 9.7% stake in SNTI and may seek to influence the companySource5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 13, 2026
Nantahala Capital Management, LLC cut its SNTI stake below 5% (4.1%)SourceInsider trade · Traded Feb 4, 2025 · Filed Feb 7, 2025
CEO sold ~$16K of SNTI shares in the open marketSourceInsider trade · Traded Feb 6, 2025 · Filed Feb 7, 2025
CEO sold ~$2.4K of SNTI shares in the open marketSourceInsider trade · Traded Feb 4, 2025 · Filed Feb 7, 2025
Officer sold ~$5.3K of SNTI shares in the open marketSourceInsider trade · Traded Feb 6, 2025 · Filed Feb 7, 2025
Officer sold ~$795 of SNTI shares in the open marketSource